The Gist Healthcare Podcast Monday, August 25, 2025
Aug 25, 2025
The Department of Health and Human Services is forming an advisory committee to rethink federal health insurance programs like Medicare and Medicaid. A recent court ruling has also overturned Biden-era marketing rules for Medicare Advantage. In corporate news, Johnson & Johnson plans a significant $2 billion investment to boost U.S. pharmaceutical manufacturing. Additionally, a report shows a rise in Medicare patients leaving hospitals against medical advice, raising concerns in the healthcare community.
AI Snips
Chapters
Transcript
Episode notes
New Federal Health Insurance Advisory Panel
- HHS will create a 15-member external advisory committee to recommend changes across Medicare, Medicaid, CHIP, and ACA exchanges.
- The panel targets chronic disease prevention, primary care access, and faster claims processing under the Make America Healthy Again agenda.
Court Overturns Most MA Marketing Rules
- A federal judge vacated most of a Biden-era Medicare Advantage marketing rule limiting broker compensation and certain plan-marketing contracts.
- The court ruled CMS lacks authority to regulate plans' marketing contracts beyond direct compensation but kept a data-sharing protection.
Review Broker Contracts And Data Sharing
- Plans and brokers should review how the ruling changes permissible compensation and contract practices immediately.
- Ensure compliance with the court-upheld data-sharing restriction to avoid unlawful disclosure of member personal data.